Teiji Takechi Selected Research

Teiji Takechi Research Topics

Disease

18	Neoplasms (Cancer) 10/2019 - 12/2002
17	Colorectal Neoplasms (Colorectal Cancer) 10/2019 - 07/2003
8	Stomach Neoplasms (Stomach Cancer) 07/2021 - 12/2002
3	Breast Neoplasms (Breast Cancer) 09/2019 - 05/2012
2	Body Weight (Weight, Body) 01/2017 - 05/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2012 - 12/2009
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Rectal Neoplasms (Rectal Cancer) 12/2017
1	Esophageal Squamous Cell Carcinoma 01/2015
1	Colonic Neoplasms (Colon Cancer) 07/2012
1	Body Weight Changes 05/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2009
1	Adenocarcinoma 12/2009

Drug/Important Bio-Agent (IBA)

19	Fluorouracil (Carac)FDA LinkGeneric 09/2019 - 12/2002
10	trifluridine tipiracil drug combinationIBA 07/2021 - 03/2015
8	Trifluridine (Viroptic)FDA LinkGeneric 10/2019 - 05/2015
6	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 02/2016 - 12/2002
5	Thymidylate SynthaseIBA 03/2018 - 12/2002
5	Pharmaceutical PreparationsIBA 01/2018 - 01/2015
4	Antineoplastic Agents (Antineoplastics)IBA 07/2019 - 05/2015
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 06/2006
4	Thymidine PhosphorylaseIBA 02/2016 - 12/2002
4	Capecitabine (Xeloda)FDA Link 07/2012 - 07/2005
3	tipiracilIBA 10/2019 - 05/2015
3	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 03/2007
3	Folic Acid (Vitamin M)FDA LinkGeneric 02/2016 - 12/2009
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2016 - 07/2012
3	Messenger RNA (mRNA)IBA 02/2016 - 12/2002
3	EnzymesIBA 01/2016 - 07/2003
3	Leucovorin (Folinic Acid)FDA Link 01/2016 - 07/2012
3	NucleosidesIBA 09/2015 - 07/2003
3	TegafurIBA 04/2007 - 07/2005
3	UracilIBA 04/2007 - 07/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2016 - 05/2012
2	Cetuximab (Erbitux)FDA Link 05/2015 - 05/2012
2	Bevacizumab (Avastin)FDA Link 05/2015 - 05/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2006 - 12/2002
1	Estrogens (Estrogen)FDA Link 09/2019
1	Hormones (Hormone)IBA 09/2019
1	Fulvestrant (Faslodex)FDA Link 09/2019
1	regorafenibIBA 09/2018
1	gimeracilIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2017
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2017
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 01/2017
1	nintedanibIBA 12/2016
1	Drug CombinationsIBA 12/2016
1	ErbB Receptors (EGF Receptor)IBA 02/2016
1	folylpolyglutamate synthetaseIBA 02/2016
1	Biological ProductsIBA 02/2016
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 02/2016
1	gamma-Glutamyl Hydrolase (Carboxypeptidase G2)IBA 02/2016
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 02/2016
1	5-fluoro-2'-deoxyuridineIBA 01/2016
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Panitumumab (Vectibix)FDA Link 05/2015
1	Sorafenib (BAY 43-9006)FDA Link 05/2012
1	AntibodiesIBA 05/2012
1	Sunitinib (Sutent)FDA Link 05/2012
1	Tyrosine Kinase InhibitorsIBA 05/2012
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2012
1	tegafur-gimeracil-oteracilIBA 06/2006
1	Cisplatin (Platino)FDA LinkGeneric 06/2006
1	TransferasesIBA 07/2005
1	potassium oxonateIBA 07/2005
1	PyrimidinesIBA 07/2005
1	doxifluridineIBA 07/2005
1	BromidesIBA 07/2003
1	Uridine PhosphorylaseIBA 12/2002
1	Transcription Factors (Transcription Factor)IBA 12/2002
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2002
1	XenobioticsIBA 12/2002
1	ProdrugsIBA 12/2002
1	Taxoids (Taxanes)IBA 12/2002
1	InterferonsIBA 12/2002
1	Adenosine Triphosphate (ATP)IBA 12/2002

Therapy/Procedure

14	Therapeutics 10/2019 - 05/2012
11	Drug Therapy (Chemotherapy) 10/2019 - 06/2006
4	Combination Drug Therapy (Combination Chemotherapy) 09/2015 - 07/2012
1	Chemoradiotherapy 12/2017
1	Radiotherapy 12/2017
1	Aftercare (After-Treatment) 01/2017